| Symbol |
Name |
Standardized Value |
|
CD34
|
CD34 molecule
|
2.883
|
|
TSC2
|
tuberous sclerosis 2
|
2.793
|
|
USP6
|
ubiquitin specific peptidase 6
|
2.708
|
|
TSC1
|
tuberous sclerosis 1
|
2.694
|
|
PTCH1
|
patched 1
|
2.687
|
|
CD99
|
CD99 molecule
|
2.642
|
|
CD99L2
|
CD99 molecule-like 2
|
2.64
|
|
CALB2
|
calbindin 2
|
2.601
|
|
CALD1
|
caldesmon 1
|
2.383
|
|
SUFU
|
suppressor of fused homolog (Drosophila)
|
2.289
|
|
NF1
|
neurofibromin 1
|
2.288
|
|
PTCH2
|
patched 2
|
2.228
|
|
FLCN
|
folliculin
|
2.217
|
|
CD68
|
CD68 molecule
|
2.203
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
2.18
|
|
CDC73
|
cell division cycle 73
|
2.176
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
2.147
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
2.079
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
2.075
|
|
FOXL2
|
forkhead box L2
|
2.053
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
2.042
|
|
KRT7
|
keratin 7, type II
|
2.035
|
|
TP53
|
tumor protein p53
|
2.029
|
|
MME
|
membrane metallo-endopeptidase
|
2.025
|
|
SATB2
|
SATB homeobox 2
|
1.992
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
1.963
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.946
|
|
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2)
|
1.945
|
|
EWSR1
|
EWS RNA-binding protein 1
|
1.939
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
1.9
|
|
WT1
|
Wilms tumor 1
|
1.878
|
|
KRT14
|
keratin 14, type I
|
1.874
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
1.873
|
|
ODAM
|
odontogenic, ameloblast asssociated
|
1.871
|
|
GNAS
|
GNAS complex locus
|
1.865
|
|
PTEN
|
phosphatase and tensin homolog
|
1.853
|
|
KRT5
|
keratin 5, type II
|
1.85
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
1.846
|
|
FGF23
|
fibroblast growth factor 23
|
1.846
|
|
KRT19
|
keratin 19, type I
|
1.839
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
1.835
|
|
PGR
|
progesterone receptor
|
1.813
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
1.809
|
|
KRT20
|
keratin 20, type I
|
1.803
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
1.801
|
|
AFP
|
alpha-fetoprotein
|
1.797
|
|
SYP
|
synaptophysin
|
1.772
|
|
H3-3A
|
H3.3 histone A
|
1.764
|
|
SHH
|
sonic hedgehog
|
1.762
|
|
MYOG
|
myogenin (myogenic factor 4)
|
1.761
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
1.745
|
|
MEN1
|
multiple endocrine neoplasia I
|
1.744
|
|
FN1
|
fibronectin 1
|
1.738
|
|
PTH
|
parathyroid hormone
|
1.737
|
|
ESR1
|
estrogen receptor 1
|
1.708
|
|
GLI1
|
GLI family zinc finger 1
|
1.678
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.678
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
1.672
|
|
TBC1D7
|
TBC1 domain family, member 7
|
1.672
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
1.667
|
|
NF2
|
neurofibromin 2 (merlin)
|
1.659
|
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
|
1.65
|
|
RHEB
|
Ras homolog enriched in brain
|
1.626
|
|
MUC4
|
mucin 4, cell surface associated
|
1.619
|
|
AMTN
|
amelotin
|
1.612
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
1.612
|
|
AMBN
|
ameloblastin (enamel matrix protein)
|
1.612
|
|
CD1E
|
CD1e molecule
|
1.61
|
|
CD1A
|
CD1a molecule
|
1.608
|
|
PAX8
|
paired box 8
|
1.605
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.598
|
|
CDK4
|
cyclin-dependent kinase 4
|
1.592
|
|
CD1B
|
CD1b molecule
|
1.592
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
1.587
|
|
GLI2
|
GLI family zinc finger 2
|
1.583
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
1.573
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
1.568
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
1.564
|
|
COL1A1
|
collagen, type I, alpha 1
|
1.557
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
1.554
|
|
SMO
|
smoothened, frizzled class receptor
|
1.548
|
|
KRT8
|
keratin 8, type II
|
1.545
|
|
IGF2
|
insulin-like growth factor 2
|
1.54
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
1.54
|
|
PXDNL
|
peroxidasin-like
|
1.518
|
|
PXDN
|
peroxidasin
|
1.516
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
1.516
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
1.515
|
|
CD1C
|
CD1c molecule
|
1.511
|
|
CRP
|
C-reactive protein, pentraxin-related
|
1.498
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
1.495
|
|
PCNA
|
proliferating cell nuclear antigen
|
1.495
|
|
IHH
|
indian hedgehog
|
1.489
|
|
CD1D
|
CD1d molecule
|
1.483
|
|
EGFR
|
epidermal growth factor receptor
|
1.479
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
1.473
|
|
AMH
|
anti-Mullerian hormone
|
1.465
|
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B
|
1.463
|
|
CCND1
|
cyclin D1
|
1.453
|
|
VEGFD
|
vascular endothelial growth factor D
|
1.444
|
|
EGF
|
epidermal growth factor
|
1.444
|
|
MEPE
|
matrix extracellular phosphoglycoprotein
|
1.44
|
|
PRDM10
|
PR domain containing 10
|
1.437
|
|
MYOD1
|
myogenic differentiation 1
|
1.429
|
|
KRT10
|
keratin 10, type I
|
1.428
|
|
RUNX2
|
runt-related transcription factor 2
|
1.426
|
|
ELN
|
elastin
|
1.425
|
|
FGF7
|
fibroblast growth factor 7
|
1.422
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
1.416
|
|
FOSL1
|
FOS-like antigen 1
|
1.412
|
|
PDPN
|
podoplanin
|
1.41
|
|
GFAP
|
glial fibrillary acidic protein
|
1.403
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
1.401
|
|
MUTYH
|
mutY homolog
|
1.4
|
|
SH3BP2
|
SH3-domain binding protein 2
|
1.381
|
|
SSX2
|
synovial sarcoma, X breakpoint 2
|
1.38
|
|
STK11
|
serine/threonine kinase 11
|
1.379
|
|
APC
|
adenomatous polyposis coli
|
1.377
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.371
|
|
BRCA1
|
breast cancer 1, early onset
|
1.37
|
|
POMC
|
proopiomelanocortin
|
1.357
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
1.356
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
1.353
|
|
H3-3B
|
H3.3 histone B
|
1.351
|
|
IL6
|
interleukin 6
|
1.35
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
1.349
|
|
NES
|
nestin
|
1.346
|
|
PRL
|
prolactin
|
1.344
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
1.337
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
1.335
|
|
FUS
|
FUS RNA binding protein
|
1.323
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
1.321
|
|
FNIP1
|
folliculin interacting protein 1
|
1.321
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
1.32
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
1.32
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
1.317
|
|
SSX1
|
synovial sarcoma, X breakpoint 1
|
1.316
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
1.311
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
1.309
|
|
ALB
|
albumin
|
1.303
|
|
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
|
1.303
|
|
MUC1
|
mucin 1, cell surface associated
|
1.303
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
1.298
|
|
SFRP4
|
secreted frizzled-related protein 4
|
1.295
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
1.295
|
|
CHGA
|
chromogranin A
|
1.294
|
|
FLNA
|
filamin A, alpha
|
1.291
|
|
FGF18
|
fibroblast growth factor 18
|
1.288
|
|
KRT13
|
keratin 13, type I
|
1.287
|
|
FGF3
|
fibroblast growth factor 3
|
1.283
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
1.282
|
|
NFIC
|
nuclear factor I/C (CCAAT-binding transcription factor)
|
1.278
|
|
PTHLH
|
parathyroid hormone-like hormone
|
1.277
|
|
S100A9
|
S100 calcium binding protein A9
|
1.273
|
|
FGF4
|
fibroblast growth factor 4
|
1.272
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
1.272
|
|
FGF10
|
fibroblast growth factor 10
|
1.268
|
|
FGF9
|
fibroblast growth factor 9
|
1.268
|
|
NCOA2
|
nuclear receptor coactivator 2
|
1.267
|
|
FGF22
|
fibroblast growth factor 22
|
1.266
|
|
FGF16
|
fibroblast growth factor 16
|
1.264
|
|
FGF6
|
fibroblast growth factor 6
|
1.264
|
|
BRCA2
|
breast cancer 2, early onset
|
1.264
|
|
FGF20
|
fibroblast growth factor 20
|
1.262
|
|
CAMTA1
|
calmodulin binding transcription activator 1
|
1.262
|
|
MUC16
|
mucin 16, cell surface associated
|
1.26
|
|
KLLN
|
killin, p53-regulated DNA replication inhibitor
|
1.26
|
|
THRAP3
|
thyroid hormone receptor associated protein 3
|
1.259
|
|
FGF17
|
fibroblast growth factor 17
|
1.259
|
|
FGF5
|
fibroblast growth factor 5
|
1.256
|
|
VIM
|
vimentin
|
1.252
|
|
MMP2
|
matrix metallopeptidase 2
|
1.251
|
|
MSH6
|
mutS homolog 6
|
1.249
|
|
INS
|
insulin
|
1.248
|
|
YJEFN3
|
YjeF N-terminal domain containing 3
|
1.246
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
1.242
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
1.242
|
|
RET
|
ret proto-oncogene
|
1.234
|
|
KITLG
|
KIT ligand
|
1.232
|
|
SPP1
|
secreted phosphoprotein 1
|
1.231
|
|
HMGA2
|
high mobility group AT-hook 2
|
1.228
|
|
ZNF444
|
zinc finger protein 444
|
1.224
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
1.217
|
|
ACR
|
acrosin
|
1.216
|
|
RPS6
|
ribosomal protein S6
|
1.213
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
1.211
|
|
TNF
|
tumor necrosis factor
|
1.211
|
|
TGFA
|
transforming growth factor, alpha
|
1.206
|
|
MED12
|
mediator complex subunit 12
|
1.199
|
|
CREB3L1
|
cAMP responsive element binding protein 3-like 1
|
1.199
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
1.198
|
|
HACD1
|
3-hydroxyacyl-CoA dehydratase 1
|
1.189
|
|
GLI3
|
GLI family zinc finger 3
|
1.189
|
|
CD207
|
CD207 molecule, langerin
|
1.189
|
|
MITF
|
microphthalmia-associated transcription factor
|
1.185
|
|
COL12A1
|
collagen, type XII, alpha 1
|
1.183
|
|
CCNB3
|
cyclin B3
|
1.183
|
|
SOS1
|
son of sevenless homolog 1 (Drosophila)
|
1.182
|
|
MMP9
|
matrix metallopeptidase 9
|
1.173
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
1.17
|
|
SALL4
|
spalt-like transcription factor 4
|
1.17
|
|
KRT17
|
keratin 17, type I
|
1.17
|
|
POU5F1
|
POU class 5 homeobox 1
|
1.169
|
|
CREB3L2
|
cAMP responsive element binding protein 3-like 2
|
1.167
|
|
TP63
|
tumor protein p63
|
1.166
|
|
MSH2
|
mutS homolog 2
|
1.166
|
|
AFAP1
|
actin filament associated protein 1
|
1.166
|
|
SST
|
somatostatin
|
1.164
|
|
COL6A3
|
collagen, type VI, alpha 3
|
1.163
|
|
TERT
|
telomerase reverse transcriptase
|
1.158
|
|
DEFA1
|
defensin, alpha 1
|
1.157
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
1.157
|
|
NOAZFP
|
nucleolar atypical zinc finger
|
1.155
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
1.154
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
1.15
|
|
ALPP
|
alkaline phosphatase, placental
|
1.15
|
|
NKX2-1
|
NK2 homeobox 1
|
1.134
|
|
CD44
|
CD44 molecule (Indian blood group)
|
1.127
|
|
ZNF225
|
zinc finger protein 225
|
1.127
|
|
KRT18
|
keratin 18, type I
|
1.124
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
1.124
|
|
MLH1
|
mutL homolog 1
|
1.119
|
|
CDX2
|
caudal type homeobox 2
|
1.115
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
1.111
|
|
CD8A
|
CD8a molecule
|
1.11
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
1.109
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
1.109
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
1.106
|
|
SSX4B
|
synovial sarcoma, X breakpoint 4B
|
1.093
|
|
PRX
|
periaxin
|
1.092
|
|
CTSK
|
cathepsin K
|
1.091
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
1.088
|
|
CD4
|
CD4 molecule
|
1.087
|
|
SSX4
|
synovial sarcoma, X breakpoint 4
|
1.086
|
|
CD163
|
CD163 molecule
|
1.086
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
1.084
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
1.081
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
1.078
|
|
IL1B
|
interleukin 1, beta
|
1.076
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
1.076
|
|
EREG
|
epiregulin
|
1.074
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
1.074
|
|
PRKACG
|
protein kinase, cAMP-dependent, catalytic, gamma
|
1.074
|
|
HEY1
|
hes-related family bHLH transcription factor with YRPW motif 1
|
1.073
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
1.069
|
|
DEFA1B
|
defensin, alpha 1B
|
1.069
|
|
SS18
|
synovial sarcoma translocation, chromosome 18
|
1.059
|
|
VGLL2
|
vestigial-like family member 2
|
1.059
|
|
AXIN1
|
axin 1
|
1.058
|
|
MMP1
|
matrix metallopeptidase 1
|
1.053
|
|
MB
|
myoglobin
|
1.046
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
1.033
|
|
FOXE1
|
forkhead box E1
|
1.031
|
|
SP7
|
Sp7 transcription factor
|
1.031
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
1.03
|
|
VGLL3
|
vestigial-like family member 3
|
1.029
|
|
HHIP
|
hedgehog interacting protein
|
1.029
|
|
IBSP
|
integrin-binding sialoprotein
|
1.027
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
1.027
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
1.022
|
|
PIP
|
prolactin-induced protein
|
1.021
|
|
IFNG
|
interferon, gamma
|
1.021
|
|
SPRED1
|
sprouty-related, EVH1 domain containing 1
|
1.019
|
|
TCHP
|
trichoplein, keratin filament binding
|
1.019
|
|
DICER1
|
dicer 1, ribonuclease type III
|
1.017
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
1.014
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
1.012
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
1.01
|
|
EPCAM
|
epithelial cell adhesion molecule
|
1.008
|
|
SULT1C2
|
sulfotransferase family, cytosolic, 1C, member 2
|
1.007
|
|
FHL2
|
four and a half LIM domains 2
|
1.006
|
|
POLE
|
polymerase (DNA directed), epsilon, catalytic subunit
|
1.006
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
1.002
|
|
MSX2
|
msh homeobox 2
|
1.002
|
|
SDC1
|
syndecan 1
|
1.002
|
|
CCN2
|
cellular communication network factor 2
|
1.001
|
